Enzo Biochem (ENZ -9.3%) takes a hit after its FQ1 misses across the board. Net losses widened...

|About: Enzo Biochem, Inc. (ENZ)|By:, SA News Editor

Enzo Biochem (ENZ -9.3%) takes a hit after its FQ1 misses across the board. Net losses widened Y/Y, as royalty payments declined and operating expenses jumped 11% due to higher SG&A expenses.